Hawkins (HWKN) 10-Q1 Nov 232024 Q2 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Oct. 01, 2023	Oct. 27, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 01, 2023
Document Transition Report	false
Entity File Number	0-7647
Entity Registrant Name	HAWKINS, INC.
Entity Incorporation, State or Country Code	MN
Entity Tax Identification Number	41-0771293
Entity Address, Address Line One	2381 Rosegate
Entity Address, City or Town	Roseville
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55113
City Area Code	612
Local Phone Number	331-6910
Title of 12(b) Security	Common Stock, par value $.01 per share
Trading Symbol	HWKN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		20,943,750
Entity Central Index Key	0000046250
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--03-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Assets, Current [Abstract]
Cash and cash equivalents	$ 10,974	$ 7,566
Trade accounts receivables, net	124,813	129,252
Inventories	68,500	88,777
Prepaid expenses and other current assets	2,966	6,449
Total current assets	207,253	232,044
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT, AND EQUIPMENT:	361,362	344,753
Less accumulated depreciation	168,504	158,950
Net property, plant, and equipment	192,858	185,803
Other Assets [Abstract]
Right-of-use assets	11,323	10,199
Goodwill	77,401	77,401
Intangible assets, net of accumulated amortization	71,491	73,060
Deferred compensation plan asset	8,917	7,367
Other	6,054	4,661
Total other assets	175,186	172,688
Total assets	575,297	590,535
Liabilities, Current [Abstract]
Accounts payable — trade	61,192	53,705
Accrued payroll and employee benefits	12,416	17,279
Income tax payable	4,319	3,329
Current portion of long-term debt	9,913	9,913
Other current liabilities	6,622	6,645
Total current liabilities	94,462	90,871
LONG-TERM DEBT, LESS CURRENT PORTION	49,775	101,731
LONG-TERM LEASE LIABILITY	9,522	8,687
PENSION WITHDRAWAL LIABILITY	3,726	3,912
DEFERRED INCOME TAXES	24,190	23,800
DEFERRED COMPENSATION LIABILITY	10,317	9,343
OTHER LONG-TERM LIABILITIES	649	2,175
Total liabilities	192,641	240,519
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,787,626 and 20,850,454 shares issued and outstanding as of October 1, 2023 and April 2, 2023, respectively	208	209
Additional paid-in capital	35,918	44,443
Retained earnings	342,535	302,424
Accumulated other comprehensive income	3,995	2,940
Total shareholders’ equity	382,656	350,016
Total liabilities and shareholders’ equity	$ 575,297	$ 590,535

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - $ / shares	Oct. 01, 2023	Apr. 02, 2023
Statement of Financial Position [Abstract]
Common Stock, Shares Authorized	60,000,000	60,000,000
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common Stock, Shares, Issued	20,787,626	20,850,454
Common Stock, Shares, Outstanding	20,787,626	20,850,454

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Income Statement [Abstract]
Sales	$ 236,526	$ 241,192	$ 487,646	$ 487,735
Cost of sales	(182,640)	(194,818)	(381,769)	(394,612)
Gross profit	53,886	46,374	105,877	93,123
Selling, general and administrative expenses	(20,895)	(19,838)	(40,399)	(38,723)
Operating income	32,991	26,536	65,478	54,400
Interest expense, net	(717)	(1,383)	(1,865)	(2,312)
Other (expense) income	(289)	(446)	48	(1,209)
Income before income taxes	31,985	24,707	63,661	50,879
Income tax expense	(8,769)	(6,707)	(17,015)	(13,184)
Net income	$ 23,216	$ 18,000	$ 46,646	$ 37,695
Weighted average number of shares outstanding - basic	20,903,690	20,814,686	20,905,707	20,861,754
Weighted average number of shares outstanding - diluted	21,026,428	20,956,897	21,034,153	21,004,454
Basic earnings per share
Basic earnings per share	$ 1.11	$ 0.86	$ 2.23	$ 1.81
Diluted earnings per share
Diluted earnings per share	1.10	0.86	2.22	1.79
Cash dividends declared per common share	$ 0.16	$ 0.14	$ 0.31	$ 0.28

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Other comprehensive income (loss), net of tax:
Net income	$ 23,216	$ 18,000	$ 46,646	$ 37,695
Unrealized gain on interest rate swap	306	1,977	1,055	2,442
Total comprehensive income	$ 23,522	$ 19,977	$ 47,701	$ 40,137

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Shareholder's Equity Statement - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]
Shares outstanding, beginning balance at Apr. 03, 2022		20,889,777
Stockholders' equity, beginning balance at Apr. 03, 2022	$ 302,601	$ 209	$ 46,717	$ 254,384	$ 1,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends declared and paid	(2,958)	0	0	(2,958)	0
Share-based compensation expense	595	$ 0	595	0	0
Vesting of restricted stock (shares)		102,860
Vesting of restricted stock	0	$ 1	(1)	0	0
Shares surrendered for payroll taxes (shares)		36,410
Shares surrendered for payroll taxes	(1,550)	$ 0	(1,550)	0	0
ESPP shares issued (shares)		32,768
ESPP shares issued	986	$ 0	986	0	0
Shares repurchased (shares)		(181,657)
Shares repurchased	(6,557)	$ (2)	(6,555)	0	0
Other Comprehensive Income (Loss), Net of Tax	465	0	0	0	465
Net income	19,695	$ 0	0	19,695	0
Shares outstanding, ending balance at Jul. 03, 2022		20,807,338
Stockholders' equity, ending balance at Jul. 03, 2022	$ 313,277	$ 208	40,192	271,121	1,756
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.14
Common Stock, Dividends, Per Share, Cash Paid	$ 0.14
Shares outstanding, beginning balance at Apr. 03, 2022		20,889,777
Stockholders' equity, beginning balance at Apr. 03, 2022	$ 302,601	$ 209	46,717	254,384	1,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares surrendered for payroll taxes	$ (1,550)
Shares repurchased (shares)	(181,657)
Shares repurchased	$ (6,557)
Net income	37,695
Shares outstanding, ending balance at Oct. 02, 2022		20,817,625
Stockholders' equity, ending balance at Oct. 02, 2022	$ 331,414	$ 208	41,294	286,179	3,733
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.28
Shares outstanding, beginning balance at Jul. 03, 2022		20,807,338
Stockholders' equity, beginning balance at Jul. 03, 2022	$ 313,277	$ 208	40,192	271,121	1,756
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends declared and paid	(2,942)	0	0	(2,942)	0
Share-based compensation expense	1,085	$ 0	1,085	0	0
Vesting of restricted stock (shares)		10,287
Vesting of restricted stock	0	$ 0	0	0	0
ESPP shares issued (shares)		0
ESPP shares issued	$ 17	$ 0	17	0	0
Shares repurchased (shares)	0
Other Comprehensive Income (Loss), Net of Tax	$ 1,977	0	0	0	1,977
Net income	18,000	$ 0	0	18,000	0
Shares outstanding, ending balance at Oct. 02, 2022		20,817,625
Stockholders' equity, ending balance at Oct. 02, 2022	$ 331,414	$ 208	41,294	286,179	3,733
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.14
Common Stock, Dividends, Per Share, Cash Paid	$ 0.14
Shares outstanding, beginning balance at Apr. 02, 2023		20,850,454
Stockholders' equity, beginning balance at Apr. 02, 2023	$ 350,016	$ 209	44,443	302,424	2,940
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends declared and paid	(3,160)	0	0	(3,160)	0
Share-based compensation expense	959	$ 0	959	0	0
Vesting of restricted stock (shares)		105,600
Vesting of restricted stock	0	$ 1	(1)	0	0
Shares surrendered for payroll taxes (shares)		(48,478)
Shares surrendered for payroll taxes	(2,140)	$ (1)	(2,139)	0	0
ESPP shares issued (shares)		35,281
ESPP shares issued	1,147	$ 0	1,147	0	0
Other Comprehensive Income (Loss), Net of Tax	749	0	0	0	749
Net income	23,430	$ 0	0	23,430	0
Shares outstanding, ending balance at Jul. 02, 2023		20,942,857
Stockholders' equity, ending balance at Jul. 02, 2023	$ 371,001	$ 209	44,409	322,694	3,689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.15
Common Stock, Dividends, Per Share, Cash Paid	$ 0.15
Shares outstanding, beginning balance at Apr. 02, 2023		20,850,454
Stockholders' equity, beginning balance at Apr. 02, 2023	$ 350,016	$ 209	44,443	302,424	2,940
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares surrendered for payroll taxes	$ (2,140)
Shares repurchased (shares)	(167,796)
Shares repurchased	$ (9,752)
Net income	46,646
Shares outstanding, ending balance at Oct. 01, 2023		20,787,626
Stockholders' equity, ending balance at Oct. 01, 2023	$ 382,656	$ 208	35,918	342,535	3,995
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.31
Shares outstanding, beginning balance at Jul. 02, 2023		20,942,857
Stockholders' equity, beginning balance at Jul. 02, 2023	$ 371,001	$ 209	44,409	322,694	3,689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends declared and paid	(3,375)	0	0	(3,375)	0
Share-based compensation expense	1,260	$ 0	1,260	0	0
Vesting of restricted stock (shares)		12,565
Vesting of restricted stock	$ 0	$ 0	0	0	0
Shares repurchased (shares)	(167,796)	(167,796)
Shares repurchased	$ (9,752)	$ (1)	(9,751)	0	0
Other Comprehensive Income (Loss), Net of Tax	306	0	0	0	306
Net income	23,216	$ 0	0	23,216	0
Shares outstanding, ending balance at Oct. 01, 2023		20,787,626
Stockholders' equity, ending balance at Oct. 01, 2023	$ 382,656	$ 208	$ 35,918	$ 342,535	$ 3,995
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.16
Common Stock, Dividends, Per Share, Cash Paid	$ 0.16

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 46,646	$ 37,695
Reconciliation to cash flows:
Depreciation and amortization	14,506	13,371
Operating leases	1,115	945
(Gain) loss on deferred compensation assets	(48)	1,208
Stock compensation expense	2,219	1,680
Other	(34)	187
Changes in operating accounts providing (using) cash:
Trade receivables	4,909	(8,481)
Inventories	20,752	(18,077)
Accounts payable	6,421	(4,609)
Accrued liabilities	(7,149)	(8,600)
Lease liabilities	(1,127)	(972)
Income taxes	990	2,031
Other	3,430	2,425
Net cash provided by operating activities	92,630	18,803
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, and equipment	(16,922)	(20,668)
Acquisitions	(3,355)	0
Other	335	296
Net cash used in investing activities	(19,942)	(20,372)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends declared and paid	(6,535)	(5,900)
New shares issued	1,147	1,004
Payroll taxes paid in exchange for shares withheld	(2,140)	(1,550)
Shares repurchased	(9,752)	(6,557)
Payments on revolving loan	(52,000)	(30,000)
Proceeds from revolving loan borrowings	0	45,000
Net cash (used in) provided by financing activities	(69,280)	1,997
NET INCREASE IN CASH AND CASH EQUIVALENTS	3,408	428
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	10,974	3,924
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for income taxes	16,025	11,148
Cash paid for interest	2,002	1,879
Noncash investing activities - capital expenditures in accounts payable	$ 2,970	$ 2,535

Accounting Policies

Accounting Policies	6 Months Ended
Accounting Policies	Oct. 01, 2023
Accounting Policies [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Basis of Presentation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q and, accordingly, do not include all information and footnotes required by generally accepted accounting principles for complete financial statements. These financial statements should be read in conjunction with the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the fiscal year ended April 2, 2023 , previously filed with the Securities and Exchange Commission (“SEC”). In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly our financial position and the results of our operations and cash flows for the periods presented. All adjustments made to the interim condensed consolidated financial statements were of a normal recurring nature. All significant intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the six months ended October 1, 2023 are not necessarily indicative of the results that may be expected for the full year. References to fiscal 2023 refer to the fiscal year ended April 2, 2023 and references to fiscal 2024 refer to the fiscal year ending March 31, 2024. Use of Estimates. The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, particularly receivables, inventories, property, plant and equipment, right-of-use assets, goodwill, intangibles, accrued expenses, short-term and long-term lease liability, income taxes and related accounts and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Accounting Policies. The accounting policies we follow are set forth in Note 1 – Nature of Business and Significant Accounting Policies to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended April 2, 2023 , previously filed with the SEC. There has been no significant change in our accounting policies since the end of fiscal 2023.

Business Combinations

Business Combinations	6 Months Ended
Business Combinations	Oct. 01, 2023
Business Combinations [Abstract]
Business Combination Disclosure	Acquisitions and Asset Sales Acquisition of EcoTech Enterprises, Inc.: On July 14, 2023, we acquired substantially all the assets of EcoTech Enterprises, Inc. ("EcoTech") for $3.4 million, under the terms of a purchase agreement with EcoTech and its shareholders. EcoTech was a water treatment chemical distribution company operating primarily in Arkansas. The $3.4 million purchase price was allocated primarily to customer lists, to be amortized over 10 years, property, plant and equipment, and net working capital. The results of operations since the acquisition date and the assets are included in our Water Treatment segment. Costs associated with this transaction were not material and were expensed as incurred. Sale of bleach packaging assets: In the fourth quarter of fiscal 2023, we sold certain assets in our Industrial segment related to our consumer bleach packaging business for $7 million. These assets were not core to our Industrial segment operations, where we tend to focus our manufacturing operations on bulk products. The assets sold included plant equipment, inventory and intangible assets, all related to the packaging of bleach. We realized a gain of $3 million on this sale, which has been recorded within selling, general and administrative expenses.

Revenue

Revenue	6 Months Ended
Revenue	Oct. 01, 2023
Disaggregation of Revenue [Abstract]
Revenue from Contract with Customer	Revenue Our revenue arrangements generally consist of a single performance obligation to transfer promised goods or services. We disaggregate revenues from contracts with customers by operating segments as well as types of products sold. Reporting by operating segment is pertinent to understanding our revenues, as it aligns to how we review the financial performance of our operations. Types of products sold within each operating segment help us to further evaluate the financial performance of our segments. The following tables disaggregate external customer net sales by major revenue stream for the six months ended October 1, 2023 and October 2, 2022: Three months ended October 1, 2023 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 83,890 $ 90,964 $ 10,858 $ 185,712 Distributed specialty products (2) — — 26,113 26,113 Bulk products (3) 13,149 8,560 — 21,709 Other 1,496 1,401 95 2,992 Total external customer sales $ 98,535 $ 100,925 $ 37,066 $ 236,526 Three months ended October 2, 2022 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 93,548 $ 77,172 $ 11,736 $ 182,456 Distributed specialty products (2) — — 28,677 28,677 Bulk products (3) 18,132 7,720 — 25,852 Other 2,259 1,596 352 4,207 Total external customer sales $ 113,939 $ 86,488 $ 40,765 $ 241,192 Six months ended October 1, 2023 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 186,565 $ 175,749 $ 21,099 $ 383,413 Distributed specialty products (2) — — 52,267 52,267 Bulk products (3) 28,359 16,081 — 44,440 Other 4,484 2,746 296 7,526 Total external customer sales $ 219,408 $ 194,576 $ 73,662 $ 487,646 Six months ended October 2, 2022 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 195,160 $ 147,529 $ 23,697 $ 366,386 Distributed specialty products (2) — — 59,766 59,766 Bulk products (3) 38,587 14,510 — 53,097 Other 4,902 2,939 645 8,486 Total external customer sales $ 238,649 $ 164,978 $ 84,108 $ 487,735 (1) For our Industrial and Water Treatment segments, this line includes our non-bulk specialty products that we either manufacture, blend, repackage, resell in their original form, or direct ship to our customers in smaller quantities, and services we provide for our customers. For our Health and Nutrition segment, this line includes products manufactured, processed or repackaged in our facility and/or with our equipment. (2) This line includes non-manufactured distributed specialty products in our Health and Nutrition segment, which may be sold out of one of our facilities or direct shipped to our customers. (3) This line includes bulk products in our Industrial and Water Treatment segments that we do not modify in any way, but receive, store, and ship from our facilities, or direct ship to our customers in large quantities.

Earnings per Share

Earnings per Share	6 Months Ended
Earnings per Share	Oct. 01, 2023
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share (“EPS”) is computed by dividing net earnings by the weighted-average number of common shares outstanding. Diluted EPS includes the dilutive impact of incremental shares assumed to be issued as performance units and restricted stock. Basic and diluted EPS were calculated using the following: Three Months Ended Six Months Ended October 01, 2023 October 02, 2022 October 01, 2023 October 02, 2022 Weighted-average common shares outstanding—basic 20,903,690 20,814,686 20,905,707 20,861,754 Dilutive impact of performance units and restricted stock 122,738 142,211 128,446 142,700 Weighted-average common shares outstanding—diluted 21,026,428 20,956,897 21,034,153 21,004,454 For each of the periods presented, there were no shares excluded from the calculation of weighted-average common shares for diluted EPS.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
Fair Value Measurements	Oct. 01, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]	Fair Value Measurements Our financial assets and liabilities are measured at fair value at the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value because of the short-term nature of these instruments. Because of the variable-rate nature of our debt under our credit facility, our debt also approximates fair value. Assets and Liabilities Measured at Fair Value on a Recurring Basis. The fair value hierarchy requires the use of observable market data when available. In instances where inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. Our financial assets that are measured at fair value on a recurring basis are an interest rate swap and assets held in a deferred compensation retirement plan. Both of these assets are classified as long-term assets on our balance sheet, with the portion of the deferred compensation retirement plan assets expected to be paid within twelve months classified as current assets. The fair value of the interest rate swap is determined by the respective counterparties based on interest rate changes. Interest rate swaps are valued based on observable interest rate yield curves for similar instruments. The deferred compensation plan assets relate to contributions made to a non-qualified compensation plan on behalf of certain employees who are classified as “highly compensated employees” as determined by IRS guidelines. The assets are part of a rabbi trust and the funds are held in mutual funds. The fair value of the deferred compensation is based on the quoted market prices for the mutual funds at the end of the period. The following tables summarize the balances of assets and liabilities measured at fair value on a recurring basis as of October 1, 2023 and April 2, 2023. 0 (In thousands) October 1, 2023 April 2, 2023 Assets Deferred compensation plan assets Level 1 $ 9,058 $ 7,659 Interest rate swap Level 2 $ 5,473 $ 4,028

Inventories

Inventories	6 Months Ended
Inventories	Oct. 01, 2023
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories at October 1, 2023 and April 2, 2023 consisted of the following: October 1, April 2, (In thousands) Inventory (FIFO basis) $ 104,878 $ 128,589 LIFO reserve (36,378) (39,812) Net inventory $ 68,500 $ 88,777 The first in, first out (“FIFO”) value of inventories accounted for under the last in, first out (“LIFO”) method was $83.9 million at October 1, 2023 and $101.4 million at April 2, 2023. The remainder of the inventory was valued and accounted for under the FIFO method.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
Goodwill and Intangible Assets	Oct. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The carrying amount of goodwill was $77.4 million as of October 1, 2023 and April 2, 2023, of which $44.9 million was related to our Health and Nutrition segment, $26.0 million was related to our Water Treatment segment, and $6.5 million was related to our Industrial segment. A summary of our intangible assets as of October 1, 2023 and April 2, 2023 is as follows: October 1, 2023 April 2, 2023 (In thousands) Gross Accumulated Net Gross Accumulated Net Finite-life intangible assets Customer relationships $ 110,894 $ (41,561) $ 69,333 $ 109,107 $ (38,377) $ 70,730 Trademarks and trade names $ 6,370 $ (5,467) $ 903 $ 6,370 $ (5,267) $ 1,103 Other finite-life intangible assets 3,941 (3,913) 28 3,904 (3,904) — Total finite-life intangible assets 121,205 (50,941) 70,264 119,381 (47,548) 71,833 Indefinite-life intangible assets 1,227 — 1,227 1,227 — 1,227 Total intangible assets $ 122,432 $ (50,941) $ 71,491 $ 120,608 $ (47,548) $ 73,060

Debt

Debt	6 Months Ended
Debt	Oct. 01, 2023
Debt Disclosure [Abstract]
Debt	Debt Debt at October 1, 2023 and April 2, 2023 consisted of the following: October 1, April 2, (In thousands) Senior secured revolving loan $ 60,000 $ 112,000 Less: unamortized debt issuance costs (312) (356) Total debt, net of debt issuance costs 59,688 111,644 Less: current portion of long-term debt (9,913) (9,913) Total long-term debt $ 49,775 $ 101,731 We were in compliance with all covenants of our credit agreement as of October 1, 2023.

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Oct. 01, 2023
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Income Taxes We are subject to U.S. federal income tax as well as income tax of multiple state jurisdictions. The tax years prior to our fiscal year ended March 29, 2020 are closed to examination by the Internal Revenue Service, and with few exceptions, state and local income tax jurisdictions. Our effective income tax rate was 27% for the six months ended October 1, 2023, compared to 26% for the six months ended October 2, 2022. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes.

Share Based Compensation

Share Based Compensation	6 Months Ended
Share Based Compensation	Oct. 01, 2023
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Performance-Based Restricted Stock Units . Our Board of Directors (the “Board”) approved a performance-based equity compensation arrangement for our executive officers during the first quarters of each of fiscal 2024 and fiscal 2023. These performance-based arrangements provide for the grant of performance-based restricted stock units that represent a possible future issuance of restricted shares of our common stock based on a pre-tax income target for the applicable fiscal year. The actual number of restricted shares to be issued to each executive officer is determined when our final financial information becomes available after the applicable fiscal year and will be between zero shares and 70,859 shares in the aggregate for fiscal 2024. The restricted shares issued, if any, will fully vest approximately two years after the last day of the fiscal year on which the performance is based. We are recording the compensation expense for the outstanding performance share units and the converted restricted stock over the life of the awards. The following table represents the restricted stock activity for the six months ended October 1, 2023: Shares Weighted- Unvested at beginning of period 189,258 $ 34.64 Granted 61,819 43.06 Vested (105,600) 31.74 Unvested at end of period 145,477 $ 40.33 We recorded compensation expense related to performance share units and restricted stock of $1.0 million and $1.6 million for the three and six months ended October 1, 2023, respectively. We recorded compensation expense related to performance share units and restricted stock of $0.8 million and $1.2 million for the three and six months ended October 2, 2022, respectively. Substantially all of the compensation expense was recorded in selling, general and administrative expenses in the condensed consolidated statements of income. Restricted Stock Awards .

Share Repurchase Program

Share Repurchase Program	6 Months Ended
Share Repurchase Program	Oct. 01, 2023
Investment Company, Capital Share Transactions, Stock Repurchased [Abstract]
Share Repurchase Program	Share Repurchase Program Our Board had authorized the repurchase of up to 2.6 million shares of our outstanding common shares. The shares may be repurchased on the open market or in privately negotiated transactions subject to applicable securities laws and regulations. Upon purchase of the shares, we reduce our common stock for the par value of the shares with the excess applied against additional paid-in capital. During the three and six months ended October 1, 2023, we repurchased 167,796 shares at an aggregate purchase price of $9.8 million. During the three months ended October 2, 2022, no shares were repurchased, and during the six months ended October 2, 2022, we repurchased 181,657 shares at an aggregate purchase price of $6.6 million. As of October 1, 2023, 961,552 shares remained available to be repurchased under the share repurchase program.

Segment Information

Segment Information	6 Months Ended
Segment Information	Oct. 01, 2023
Segment Reporting [Abstract]
Segment Information	Segment Information We have three reportable segments: Industrial, Water Treatment, and Health and Nutrition. The accounting policies of the segments are the same as those described in the summary of significant accounting policies in our Annual Report on Form 10-K for the fiscal year ended April 2, 2023 . We evaluate performance based on profit or loss from operations before income taxes not including nonrecurring gains and losses. Reportable segments are defined primarily by product and type of customer. Segments are responsible for the sales, marketing and development of their products and services. We allocate certain corporate expenses to our operating segments. There are no intersegment sales and no operating segments have been aggregated. No single customer’s revenues amounted to 10% or more of our total revenue. Sales are primarily within the United States and all assets are located within the United States. (In thousands) Industrial Water Health and Nutrition Total Three months ended October 1, 2023: Sales $ 98,535 $ 100,925 $ 37,066 $ 236,526 Gross profit 17,844 29,308 6,734 53,886 Selling, general, and administrative expenses 6,806 10,145 3,944 20,895 Operating income 11,038 19,163 2,790 32,991 Three months ended October 2, 2022: Sales $ 113,939 $ 86,488 $ 40,765 $ 241,192 Gross profit 17,713 20,504 8,157 46,374 Selling, general, and administrative expenses 6,891 9,082 3,865 19,838 Operating income 10,822 11,422 4,292 26,536 Six months ended October 1, 2023: Sales $ 219,408 $ 194,576 $ 73,662 $ 487,646 Gross profit 37,150 55,716 13,011 105,877 Selling, general and administrative expenses 13,381 19,271 7,747 40,399 Operating income 23,769 36,445 5,264 65,478 Six months ended October 2, 2022: Sales $ 238,649 $ 164,978 $ 84,108 $ 487,735 Gross profit 37,722 39,457 15,944 93,123 Selling, general and administrative expenses 13,276 17,783 7,664 38,723 Operating income 24,446 21,674 8,280 54,400 No significant changes to identifiable assets by segment occurred during the six months ended October 1, 2023.

Subsequent Events

Subsequent Events	6 Months Ended
Subsequent Events	Oct. 01, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events In October 2023, we acquired substantially all the assets of Water Solutions Unlimited, Inc. ("Water Solutions") for $60 million and up to an additional $15 million to be paid after three years based on achieving certain targets, under the terms of an asset purchase agreement with Water Solutions and its shareholders. Water Solutions is a manufacturer and distributor of water treatment chemicals serving customers primarily throughout Indiana, Illinois and Michigan. The results of operations and the assets, including goodwill associated with this acquisition, if any, will be included as part of our Water Treatment segment from the date of acquisition forward. The purchase accounting for this acquisition has not yet been completed. In October 2023, we acquired substantially all the assets of Miami Products & Chemical Company ("Miami Products") for $15.5 million, under the terms of an asset purchase agreement with Miami Products and its shareholders. Miami Products is a bleach manufacturer and distributor serving customers primarily throughout Ohio and the surrounding region. The results of operations and the assets, including goodwill associated with this acquisition, if any, will be included as part of our Water Treatment segment from the date of acquisition forward. The purchase accounting for this acquisition has not yet been completed.

Revenue (Tables)

Revenue (Tables)	6 Months Ended
Revenue (Tables)	Oct. 01, 2023
Disaggregation of Revenue [Abstract]
Disaggregation of Revenue [Table Text Block]	The following tables disaggregate external customer net sales by major revenue stream for the six months ended October 1, 2023 and October 2, 2022: Three months ended October 1, 2023 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 83,890 $ 90,964 $ 10,858 $ 185,712 Distributed specialty products (2) — — 26,113 26,113 Bulk products (3) 13,149 8,560 — 21,709 Other 1,496 1,401 95 2,992 Total external customer sales $ 98,535 $ 100,925 $ 37,066 $ 236,526 Three months ended October 2, 2022 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 93,548 $ 77,172 $ 11,736 $ 182,456 Distributed specialty products (2) — — 28,677 28,677 Bulk products (3) 18,132 7,720 — 25,852 Other 2,259 1,596 352 4,207 Total external customer sales $ 113,939 $ 86,488 $ 40,765 $ 241,192 Six months ended October 1, 2023 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 186,565 $ 175,749 $ 21,099 $ 383,413 Distributed specialty products (2) — — 52,267 52,267 Bulk products (3) 28,359 16,081 — 44,440 Other 4,484 2,746 296 7,526 Total external customer sales $ 219,408 $ 194,576 $ 73,662 $ 487,646 Six months ended October 2, 2022 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 195,160 $ 147,529 $ 23,697 $ 366,386 Distributed specialty products (2) — — 59,766 59,766 Bulk products (3) 38,587 14,510 — 53,097 Other 4,902 2,939 645 8,486 Total external customer sales $ 238,649 $ 164,978 $ 84,108 $ 487,735 (1) For our Industrial and Water Treatment segments, this line includes our non-bulk specialty products that we either manufacture, blend, repackage, resell in their original form, or direct ship to our customers in smaller quantities, and services we provide for our customers. For our Health and Nutrition segment, this line includes products manufactured, processed or repackaged in our facility and/or with our equipment. (2) This line includes non-manufactured distributed specialty products in our Health and Nutrition segment, which may be sold out of one of our facilities or direct shipped to our customers. (3) This line includes bulk products in our Industrial and Water Treatment segments that we do not modify in any way, but receive, store, and ship from our facilities, or direct ship to our customers in large quantities.

Earnings per Share (Tables)

Earnings per Share (Tables)	6 Months Ended
Earnings per Share (Tables)	Oct. 01, 2023
Earnings Per Share [Abstract]
Summary of basic and diluted EPS	Basic and diluted EPS were calculated using the following: Three Months Ended Six Months Ended October 01, 2023 October 02, 2022 October 01, 2023 October 02, 2022 Weighted-average common shares outstanding—basic 20,903,690 20,814,686 20,905,707 20,861,754 Dilutive impact of performance units and restricted stock 122,738 142,211 128,446 142,700 Weighted-average common shares outstanding—diluted 21,026,428 20,956,897 21,034,153 21,004,454

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
Fair Value Measurements (Tables)	Oct. 01, 2023
Fair Value Disclosures [Abstract]
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	The following tables summarize the balances of assets and liabilities measured at fair value on a recurring basis as of October 1, 2023 and April 2, 2023. 0 (In thousands) October 1, 2023 April 2, 2023 Assets Deferred compensation plan assets Level 1 $ 9,058 $ 7,659 Interest rate swap Level 2 $ 5,473 $ 4,028

Inventories (Tables)

Inventories (Tables)	6 Months Ended
Inventories (Tables)	Oct. 01, 2023
Inventory Disclosure [Abstract]
Summary of Inventories	Inventories at October 1, 2023 and April 2, 2023 consisted of the following: October 1, April 2, (In thousands) Inventory (FIFO basis) $ 104,878 $ 128,589 LIFO reserve (36,378) (39,812) Net inventory $ 68,500 $ 88,777

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
Goodwill and Intangible Assets (Tables)	Oct. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible assets and goodwill	A summary of our intangible assets as of October 1, 2023 and April 2, 2023 is as follows: October 1, 2023 April 2, 2023 (In thousands) Gross Accumulated Net Gross Accumulated Net Finite-life intangible assets Customer relationships $ 110,894 $ (41,561) $ 69,333 $ 109,107 $ (38,377) $ 70,730 Trademarks and trade names $ 6,370 $ (5,467) $ 903 $ 6,370 $ (5,267) $ 1,103 Other finite-life intangible assets 3,941 (3,913) 28 3,904 (3,904) — Total finite-life intangible assets 121,205 (50,941) 70,264 119,381 (47,548) 71,833 Indefinite-life intangible assets 1,227 — 1,227 1,227 — 1,227 Total intangible assets $ 122,432 $ (50,941) $ 71,491 $ 120,608 $ (47,548) $ 73,060

Debt (Tables)

Debt (Tables)	6 Months Ended
Debt (Tables)	Oct. 01, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Debt at October 1, 2023 and April 2, 2023 consisted of the following: October 1, April 2, (In thousands) Senior secured revolving loan $ 60,000 $ 112,000 Less: unamortized debt issuance costs (312) (356) Total debt, net of debt issuance costs 59,688 111,644 Less: current portion of long-term debt (9,913) (9,913) Total long-term debt $ 49,775 $ 101,731

Share Based Compensation (Table

Share Based Compensation (Tables)	6 Months Ended
Share Based Compensation (Tables)	Oct. 01, 2023
Performance-Based Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of performance-based restricted stock units	The following table represents the restricted stock activity for the six months ended October 1, 2023: Shares Weighted- Unvested at beginning of period 189,258 $ 34.64 Granted 61,819 43.06 Vested (105,600) 31.74 Unvested at end of period 145,477 $ 40.33

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
Segment Information (Tables)	Oct. 01, 2023
Segment Reporting [Abstract]
Summary of Segment Information	(In thousands) Industrial Water Health and Nutrition Total Three months ended October 1, 2023: Sales $ 98,535 $ 100,925 $ 37,066 $ 236,526 Gross profit 17,844 29,308 6,734 53,886 Selling, general, and administrative expenses 6,806 10,145 3,944 20,895 Operating income 11,038 19,163 2,790 32,991 Three months ended October 2, 2022: Sales $ 113,939 $ 86,488 $ 40,765 $ 241,192 Gross profit 17,713 20,504 8,157 46,374 Selling, general, and administrative expenses 6,891 9,082 3,865 19,838 Operating income 10,822 11,422 4,292 26,536 Six months ended October 1, 2023: Sales $ 219,408 $ 194,576 $ 73,662 $ 487,646 Gross profit 37,150 55,716 13,011 105,877 Selling, general and administrative expenses 13,381 19,271 7,747 40,399 Operating income 23,769 36,445 5,264 65,478 Six months ended October 2, 2022: Sales $ 238,649 $ 164,978 $ 84,108 $ 487,735 Gross profit 37,722 39,457 15,944 93,123 Selling, general and administrative expenses 13,276 17,783 7,664 38,723 Operating income 24,446 21,674 8,280 54,400

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
Business Combinations (Details) - USD ($) $ in Thousands	Jul. 14, 2023	Apr. 02, 2023	Oct. 01, 2023	Oct. 02, 2022
Asset Acquisition [Line Items]
Acquisitions	$ 3,400		$ 3,355	$ 0
Proceeds from Sale of Other Productive Assets		$ 7,000
Gain (Loss) on Disposition of Other Assets		$ 3,000

Revenue (Details)

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Revenue (Details) - USD ($) $ in Thousands	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 236,526	$ 241,192	$ 487,646	$ 487,735
Manufactured, blended or repackaged products
Disaggregation of Revenue [Line Items]
Revenue	185,712	182,456	383,413	366,386
Distributed specialty products
Disaggregation of Revenue [Line Items]
Revenue	26,113	28,677	52,267	59,766
Bulk products
Disaggregation of Revenue [Line Items]
Revenue	21,709	25,852	44,440	53,097
Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	2,992	4,207	7,526	8,486
Industrial [Member]
Disaggregation of Revenue [Line Items]
Revenue	98,535	113,939	219,408	238,649
Industrial [Member] \| Manufactured, blended or repackaged products
Disaggregation of Revenue [Line Items]
Revenue	83,890	93,548	186,565	195,160
Industrial [Member] \| Distributed specialty products
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Industrial [Member] \| Bulk products
Disaggregation of Revenue [Line Items]
Revenue	13,149	18,132	28,359	38,587
Industrial [Member] \| Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	1,496	2,259	4,484	4,902
Water Treatment [Member]
Disaggregation of Revenue [Line Items]
Revenue	100,925	86,488	194,576	164,978
Water Treatment [Member] \| Manufactured, blended or repackaged products
Disaggregation of Revenue [Line Items]
Revenue	90,964	77,172	175,749	147,529
Water Treatment [Member] \| Distributed specialty products
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Water Treatment [Member] \| Bulk products
Disaggregation of Revenue [Line Items]
Revenue	8,560	7,720	16,081	14,510
Water Treatment [Member] \| Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	1,401	1,596	2,746	2,939
Health and Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenue	37,066	40,765	73,662	84,108
Health and Nutrition [Member] \| Manufactured, blended or repackaged products
Disaggregation of Revenue [Line Items]
Revenue	10,858	11,736	21,099	23,697
Health and Nutrition [Member] \| Distributed specialty products
Disaggregation of Revenue [Line Items]
Revenue	26,113	28,677	52,267	59,766
Health and Nutrition [Member] \| Bulk products
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Health and Nutrition [Member] \| Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	$ 95	$ 352	$ 296	$ 645

Earnings per Share (Details)

Earnings per Share (Details) - shares	3 Months Ended		6 Months Ended
Earnings per Share (Details) - shares	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Summary of basic and diluted EPS
Weighted-average common shares outstanding—basic	20,903,690	20,814,686	20,905,707	20,861,754
Dilutive impact of performance units and restricted stock	122,738	142,211	128,446	142,700
Weighted-average common shares outstanding—diluted	21,026,428	20,956,897	21,034,153	21,004,454

Earnings per Share (Details Tex

Earnings per Share (Details Textual) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Earnings Per Share [Abstract]
Shares or stock options excluded from the calculation of diluted EPS	0	0	0	0

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan asset	$ 9,058	$ 7,659
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap	$ 5,473	$ 4,028

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Summary of Inventories
Inventory, Finished Goods, Gross	$ 104,878	$ 128,589
Inventory, LIFO Reserve	(36,378)	(39,812)
Inventory, Net, Total	68,500	88,777
LIFO Inventory Amount	$ 83,900	$ 101,400

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Goodwill [Line Items]
Goodwill	$ 77,401	$ 77,401
Health and Nutrition [Member]
Goodwill [Line Items]
Goodwill	44,900	44,900
Water Treatment [Member]
Goodwill [Line Items]
Goodwill	26,000	26,000
Industrial [Member]
Goodwill [Line Items]
Goodwill	$ 6,500	$ 6,500

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Summary of Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 121,205	$ 119,381
Finite-Lived Intangible Assets, Accumulated Amortization	50,941	47,548
Total finite-life intangible assets, Net	70,264	71,833
Indefinite-life intangible assets	1,227	1,227
Total Intangible Assets, Gross	122,432	120,608
Total intangible assets, net	71,491	73,060
Customer Relationships [Member]
Summary of Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	110,894	109,107
Finite-Lived Intangible Assets, Accumulated Amortization	41,561	38,377
Total finite-life intangible assets, Net	69,333	70,730
Trademarks [Member]
Summary of Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	6,370	6,370
Finite-Lived Intangible Assets, Accumulated Amortization	5,467	5,267
Total finite-life intangible assets, Net	903	1,103
Other Intangible Assets
Summary of Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	3,941	3,904
Finite-Lived Intangible Assets, Accumulated Amortization	3,913	3,904
Total finite-life intangible assets, Net	$ 28	$ 0

Debt (Details)

Debt (Details) - USD ($) $ in Thousands	Oct. 01, 2023	Apr. 02, 2023
Debt Disclosure [Abstract]
Senior secured revolving loan	$ 60,000	$ 112,000
Less: unamortized debt issuance costs	(312)	(356)
Total debt, net of debt issuance costs	59,688	111,644
Less: current portion of long-term debt	(9,913)	(9,913)
Total long-term debt	$ 49,775	$ 101,731

Income Taxes (Details)

Income Taxes (Details)	6 Months Ended
Income Taxes (Details)	Oct. 01, 2023	Oct. 02, 2022
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Percent	27%	26%

Share Based Compensation (Detai

Share Based Compensation (Details)	6 Months Ended
Share Based Compensation (Details)	Oct. 01, 2023 $ / shares shares
Performance-Based Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested at beginning of period (Shares) \| shares	189,258
Granted (Shares) \| shares	61,819
Vested (Shares) \| shares	(105,600)
Unvested at end of period (Shares) \| shares	145,477
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Beginning Balance, Weighted average grant date fair value (usd per share) \| $ / shares	$ 34.64
Granted, Weighted average grant date fair value (usd per share) \| $ / shares	43.06
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value \| $ / shares	31.74
Ending Balance, Weighted average grant date fair value (usd per share) \| $ / shares	$ 40.33
Restricted Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested at end of period (Shares) \| shares	10,647
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Ending Balance, Weighted average grant date fair value (usd per share) \| $ / shares	$ 46

Share Based Compensation (Det_2

Share Based Compensation (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	0		0
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	70,859		70,859
Performance-Based Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 1,000	$ 800	$ 1,600	$ 1,200
Restricted Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 100	$ 100	$ 200	$ 200

Share Repurchase Program (Detai

Share Repurchase Program (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Share Repurchase Program (Details) - USD ($) $ in Millions	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Investment Company, Capital Share Transactions, Stock Repurchased [Abstract]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased	2,600,000		2,600,000
Stock Repurchased During Period, Shares	167,796	0	167,796	181,657
Stock Repurchased During Period, Value	$ 9.8		$ 9.8	$ 6.6
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased	961,552		961,552

Segment Information (Details Te

Segment Information (Details Textual)	6 Months Ended
Segment Information (Details Textual)	Oct. 01, 2023 Segment
Segment Reporting [Abstract]
Number of reportable segments (segments)	3
Intersegment sales	no
Number of operating segments aggregated (segments)	0
Number of customer representing 10 percent or more of revenue (customers)	No
Quarterly Financial Information, Segment Reporting, Segment Assets, Material Change	No

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Segment Information (Details) - USD ($) $ in Thousands	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Segment Reporting Information [Line Items]
Sales	$ 236,526	$ 241,192	$ 487,646	$ 487,735
Gross profit	53,886	46,374	105,877	93,123
Selling, general, and administrative expenses	20,895	19,838	40,399	38,723
Operating income	32,991	26,536	65,478	54,400
Industrial [Member]
Segment Reporting Information [Line Items]
Sales	98,535	113,939	219,408	238,649
Gross profit	17,844	17,713	37,150	37,722
Selling, general, and administrative expenses	6,806	6,891	13,381	13,276
Operating income	11,038	10,822	23,769	24,446
Water Treatment [Member]
Segment Reporting Information [Line Items]
Sales	100,925	86,488	194,576	164,978
Gross profit	29,308	20,504	55,716	39,457
Selling, general, and administrative expenses	10,145	9,082	19,271	17,783
Operating income	19,163	11,422	36,445	21,674
Health and Nutrition [Member]
Segment Reporting Information [Line Items]
Sales	37,066	40,765	73,662	84,108
Gross profit	6,734	8,157	13,011	15,944
Selling, general, and administrative expenses	3,944	3,865	7,747	7,664
Operating income	$ 2,790	$ 4,292	$ 5,264	$ 8,280

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] $ in Thousands	1 Months Ended
	Oct. 29, 2023 USD ($)
Water Solutions
Subsequent Event [Line Items]
Payments to Acquire Businesses, Gross	$ 60,000
Business Combination, Consideration Transferred, Liabilities Incurred	15,000
Miami Products
Subsequent Event [Line Items]
Payments to Acquire Businesses, Gross	$ 15,500